ethinyl estradiol has been researched along with Androgen-Independent Prostatic Cancer in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, H; Izumi, K; Kadomoto, S; Kadono, Y; Kano, H; Makino, T; Mizokami, A; Naito, R; Shimada, T; Yaegashi, H | 1 |
| Iijima, M; Iwamoto, H; Izumi, K; Kadono, Y; Kawaguchi, S; Mizokami, A; Nakano, T; Nohara, T; Shigehara, K; Yaegashi, H | 1 |
| Furukawa, M; Hakariya, T; Matsuya, F; Miyata, Y; Sakai, H; Shida, Y; Tsurusaki, T; Watanabe, J | 1 |
| Izumi, K | 1 |
| Hayashi, T; Itatani, H; Kakuta, Y; Kamoto, A; Katayama, K; Mori, N; Sekii, Y; Yoshioka, T | 1 |
| Alfarone, A; Cattarino, S; D'Eramo, G; Gentile, V; Gentilucci, A; Salciccia, S; Sciarra, A | 1 |
| Higashi, S; Masui, S; Onishi, T; Sasaki, T; Shibahara, T; Sugino, Y | 1 |
| Bonetta, A; Cappelletti, MR; Dester, M; Generali, D; Gobbi, A; Pacifico, C; Roviello, G; Zanotti, L | 1 |
8 other study(ies) available for ethinyl estradiol and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Case-Control Studies; Chemoradiotherapy; Ethinyl Estradiol; Humans; Japan; Kallikreins; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Analysis; Treatment Outcome | 2022 |
Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer.
Topics: Aged; Aged, 80 and over; Disease Progression; Ethinyl Estradiol; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome | 2020 |
Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration-resistant prostate cancer in men.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Estrogens; Ethinyl Estradiol; Humans; Japan; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Analysis; Treatment Outcome | 2018 |
Editorial Comment to Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration-resistant prostate cancer in men.
Topics: Benzamides; Ethinyl Estradiol; Humans; Male; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant | 2018 |
[The efficacy of ethinylestradiol for castration-resistant prostate cancer].
Topics: Administration, Oral; Aged; Aged, 80 and over; Estrogens; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant | 2014 |
Oral ethinylestradiol in castration-resistant prostate cancer: a 10-year experience.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Ethinyl Estradiol; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Survival Analysis; Treatment Outcome | 2015 |
Efficacy of Ethinylestradiol Re-challenge for Metastatic Castration-resistant Prostate Cancer.
Topics: Aged; Aged, 80 and over; Ethinyl Estradiol; Humans; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies | 2016 |
Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Drug Dosage Calculations; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Survival Analysis; Treatment Outcome | 2017 |